Halberd Corp
OTC:HALB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
North Bay Resources Inc
OTC:NBRI
|
US |
Halberd Corp
Inventory
Halberd Corp
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Halberd Corp
OTC:HALB
|
Inventory
$93k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$6.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Inventory
$82.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Revolution Medicines Inc
NASDAQ:RVMD
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
United Therapeutics Corp
NASDAQ:UTHR
|
Inventory
$183.1m
|
CAGR 3-Years
22%
|
CAGR 5-Years
16%
|
CAGR 10-Years
8%
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Inventory
$153m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Halberd Corp
Glance View
Halberd Corp. is a development stage company, researches and develops antibodies and devices for the prevention, detection, and treatment of Covid-19 through laboratory, hospital, and clinical trials. The company is headquartered in Jackson Center, Pennsylvania. The company went IPO on 2009-06-12. The firm is a research-based company that intends to discover and develop medical treatments for a range of diseases. The firm's extracorporeal treatment is applicable for hard-to-cure blood-borne and neurologic diseases, such as post-traumatic stress disorder (PTSD) and Alzheimer's disease. The company is also developing treatment for coronavirus disease of 2019 (Covid-19), obesity, such as high blood pressure, diabetes, heart disease, stroke, and cancer.
See Also
What is Halberd Corp's Inventory?
Inventory
93k
USD
Based on the financial report for Jul 31, 2012, Halberd Corp's Inventory amounts to 93k USD.
What is Halberd Corp's Inventory growth rate?
Inventory CAGR 1Y
0%
Over the last year, the Inventory growth was 0%.
